Skip to main content
. 2022 Apr 9;20:164. doi: 10.1186/s12967-022-03349-z

Fig. 1.

Fig. 1

Study design and participant selection flowchart; 4754 eligible participants with available genotype information, > 19 years old, without prevalent MetS at the 1st phase and complete follow-up data from Tehran Cardio-metabolic genetic study (TCGS) were included